control
emerg
infecti
diseas
daunt
task
given
larg
number
diseasecaus
organ
abil
adapt
chang
environ
surviv
transit
develop
resist
antimicrobi
fiscal
regulatori
technic
limit
new
drug
vaccin
develop
limit
public
health
capac
constraint
health
care
deliveri
system
mention
time
space
patient
popul
consider
whether
practic
faculti
clinic
public
health
facil
hospit
base
environ
emerg
depart
urgent
care
center
common
practic
help
reduc
spread
communic
diseas
facilit
rapid
diagnosi
treatment
control
infecti
ill
moreov
one
size
fit
approach
may
appropri
health
care
commun
environ
howev
strategi
appli
near
univers
confer
benefit
varieti
set
includ
follow
patient
behavior
remain
challeng
therapeut
environ
consid
hypertens
improv
medic
life
style
adher
requir
multipl
approach
grow
obes
problem
underscor
challeng
health
care
profession
face
term
educ
motiv
help
patient
chang
lifestyl
human
human
transmiss
infect
requir
us
educ
patient
term
infect
control
measur
public
home
martin
je
louder
mk
holman
la
gordon
ij
enama
larkin
bd
et
al
june
new
cov
figur
isol
patient
die
sever
pneumonia
multiorgan
failur
saudi
arabia
newli
identifi
respiratori
viral
ill
caus
novel
coronaviru
initi
design
human
betacoronaviru
eventu
name
middl
east
respiratori
syndrom
coronaviru
mer
cov
reminisc
worth
consid
caution
greater
vigil
toward
emerg
pathogen
sudden
sar
cov
emerg
new
caus
sever
pulmonari
ill
replic
new
aggress
respiratori
ill
mer
cov
unlik
sar
cov
caus
thousand
case
short
period
time
also
differ
sar
cov
carri
much
higher
case
fatal
rate
caus
sever
ill
accord
world
health
organ
laboratori
confirm
case
mer
cov
sinc
report
countri
map
result
death
yield
signific
case
fatal
rate
fatal
rate
coronaviru
significantli
greater
associ
sar
cov
delta
least
among
confirm
case
cov
includ
sar
cov
exact
epidemiolog
includ
whether
larger
number
mild
ill
remain
unknown
male
yr
age
seem
higher
risk
sever
diseas
symptom
death
among
infect
greatest
spike
case
occur
near
new
case
continu
report
date
sinc
septemb
case
report
countri
across
contin
human
case
occur
saudi
arabia
map
mer
cov
belong
lineag
c
betacoronavirus
envelop
singl
strand
posit
sens
rna
viru
structur
protein
includ
spike
envelop
e
nucleocapsid
n
membran
protein
mer
cov
attach
host
cell
function
receptor
human
dipeptidyl
peptidas
immunogen
four
structur
protein
protein
viru
surfac
glycoproteinit
mediat
viral
attach
fusion
via
sinc
receptor
wide
found
endotheli
subendotheli
tissu
lung
gastrointestin
tract
git
kidney
may
least
part
explain
associ
multisystem
organ
failur
associ
sever
case
note
health
care
provid
accord
inform
june
outbreak
riyadh
saudi
arabia
contact
test
posit
mer
cov
index
case
present
critic
condit
hospit
confirm
anoth
case
healthcar
worker
came
contact
patient
human
human
transmiss
well
document
mostli
nosocomi
outbreak
propag
transmiss
seem
limit
healthcar
associ
cluster
mer
cov
associ
report
case
estim
ro
reproduct
rate
estim
although
health
care
set
estim
still
low
compar
measl
highli
contagi
viral
ill
notwithstand
risk
human
human
transmiss
mer
cov
infect
underst
surprisingli
diagnosi
delay
certain
region
suffer
overcrowd
poor
infect
control
measur
mer
cov
still
consid
risk
epidem
saudi
arabia
mer
cov
zoonot
viru
enter
human
popul
contact
infect
dromedari
camel
arabian
peninsula
camel
human
transmiss
known
research
suggest
mer
cov
origin
bat
camel
may
intermedi
host
close
relat
cov
found
bat
region
exampl
novel
cov
found
vesper
bat
south
africa
similar
mer
cov
differ
one
amino
acid
studi
suggest
dromedari
camel
primari
sourc
human
infect
nearli
human
case
male
median
age
among
report
case
major
case
middl
east
origin
even
though
case
report
outsid
region
like
seek
care
return
travel
cov
similar
mer
cov
case
found
camel
egypt
oman
qatar
saudi
arabia
direct
contact
saliva
infect
camel
consum
milk
meat
consid
risk
factor
one
studi
note
seropreval
mer
cov
sever
time
higher
peopl
regular
exposur
camel
compar
gener
popul
although
case
wout
contact
sick
anim
product
deriv
mer
cov
caus
spectrum
ill
rang
mild
upper
respiratori
symptom
rapidli
progress
lower
respiratori
infectionpneumonia
fever
cough
breath
difficulti
accompani
pneumonia
progress
acut
respiratori
distress
syndrom
ard
multisystem
organ
failur
death
mani
patient
present
nonpulmonari
symptom
headach
myalgia
vomit
diarrhea
mer
cov
progress
rapidli
pulmonari
failur
well
acut
kidney
injuri
aki
sar
cov
patient
underli
comorbid
associ
advanc
complic
diseas
death
essenti
healthi
patient
mer
cov
rapidli
trigger
cellular
damag
induc
proinflammatori
respons
cell
common
sign
symptom
associ
mer
cov
present
fever
cough
short
breath
typic
present
symptom
includ
fever
cough
chill
dyspnea
myalgia
abdomin
pain
nausea
vomit
diarrhea
laboratori
abnorm
associ
mer
cov
includ
thrombocytopenia
lymphopenia
leukopenia
elev
serum
lactat
dehydrogenas
ldh
elev
aspart
aminotransferas
ast
elev
alanin
aminotransferas
alt
along
abnorm
renal
function
test
superinfect
viral
bacteri
caus
found
patient
may
complic
cours
diseas
sever
case
mer
may
requir
intens
care
mechan
ventil
rel
larg
number
patient
progress
respiratori
renal
failur
retrospect
radiolog
review
ct
find
laboratori
confirm
case
mer
cov
note
cough
fever
dyspnea
common
present
symptom
three
seven
subject
die
high
case
fatal
rate
associ
mer
cov
spark
interest
role
viru
immun
system
one
area
interest
potenti
cytokin
storm
studi
shown
mer
cov
associ
attenu
interferon
ifn
respons
induc
inflammatori
cytokin
howev
studi
lau
demonstr
delay
proinflammatori
cytokin
induct
mer
cov
calu
cell
lack
product
antivir
cytokin
tnf
alpha
ifn
beta
ip
tnf
alpha
note
import
acut
phase
pyrogen
inhibit
viral
replic
ifn
beta
induc
antivir
respons
via
upregul
host
factor
attenu
tnf
alpha
ifn
beta
mer
cov
comparison
sar
cov
may
readili
evad
innat
antivir
host
immun
possibl
mer
cov
attenu
innat
immun
induc
inflammatori
respons
human
lung
epitheli
cell
also
exist
macaqu
model
mer
cov
reveal
viru
caus
local
widespread
pneumonia
infect
anim
mer
cov
note
lau
et
al
increas
il
rsv
higher
level
il
seem
correl
increas
diseas
sever
accord
cdc
data
median
incub
period
secondari
case
associ
limit
humantohuman
transmiss
approxim
day
rang
day
note
merscov
patient
median
time
ill
onset
hospit
approxim
day
critic
ill
patient
median
time
onset
intens
care
unit
icu
admiss
approxim
day
median
time
onset
death
approxim
day
one
seri
icu
patient
median
durat
mechan
ventil
day
median
icu
length
stay
day
mortal
day
chest
xray
obtain
earli
cours
progress
pulmonari
ill
albeit
ct
provid
inform
figur
radiograph
find
may
includ
unilater
bilater
patchi
densiti
opac
interstiti
infiltr
consolid
pleural
effus
rapid
progress
acut
respiratori
failur
acut
respiratori
distress
syndrom
ard
refractori
hypoxemia
extrapulmonari
complic
acut
kidney
injuri
requir
renal
replac
therapi
hypotens
requir
vasopressor
hepat
inflamm
septic
shock
report
key
appropri
test
thorough
histori
physic
import
consid
multisystem
function
well
pulmonari
statu
patient
sever
respiratori
ill
includ
suspect
mer
cov
especi
return
region
aggress
pathogen
note
involv
infecti
diseas
pulmonologist
specialist
earli
well
good
critic
care
manag
essenti
note
earlier
laboratori
find
admiss
may
includ
leukopenia
lymphopenia
thrombocytopenia
elev
lactat
dehydrogenas
level
ldh
renal
hepat
function
test
least
baselin
inform
worth
obtain
ajlan
studi
seven
patient
lymphopenia
elev
creatinin
develop
admiss
patient
ast
also
elev
patient
note
coinfect
respiratori
virus
case
coinfect
communityacquir
bacteria
admiss
report
mer
cov
patient
surprisingli
nosocomi
bacteri
fungal
infect
also
report
mechanicallyventil
patient
accord
clinic
experi
report
cdc
merscov
viru
detect
higher
viral
load
longer
durat
lower
respiratori
tract
compar
upper
respiratori
tract
detect
fece
serum
urin
howev
limit
data
avail
durat
respiratori
extrapulmonari
merscov
shed
accord
aljan
radiolog
studi
chest
xray
find
notabl
airspac
interstiti
opac
mer
cov
radiograph
find
airspac
opac
nonspecif
wherea
interstiti
chang
describ
reticular
reticulonodular
total
lung
opacif
thicken
bronchovascular
mark
report
well
previou
chest
ct
find
mer
report
bilater
patchi
extens
opac
unexpect
imag
featur
consist
acut
respiratori
distress
syndrom
typic
identifi
sicker
patient
aljan
mer
cov
common
find
ct
figur
show
airspac
opac
ct
common
patient
hospit
merscov
infect
airspac
opac
suggest
organ
pneumonia
pattern
also
describ
influenza
viral
infect
patient
groundglass
opac
extens
consolid
septal
thicken
pleural
effus
also
demonstr
importantli
treeinbud
pattern
cavit
lymph
node
enlarg
seen
cohort
chest
xray
ct
scan
figur
recommend
depend
upon
present
clinic
cours
aljan
studi
common
ct
find
hospit
patient
mer
cov
infect
reveal
predominantli
subpleur
basilar
airspac
chang
ground
glass
opac
consolid
import
note
small
studi
nevertheless
pattern
consist
organ
pneumonia
patient
recent
return
middl
east
present
signific
respiratori
ill
ct
find
peribronchi
region
abnorm
organ
pneumonia
consid
mer
cov
infect
possibl
queri
intern
travel
occup
exposur
laboratori
testingcas
definit
cdc
provid
case
definit
reader
request
review
period
site
updat
mer
cov
situat
chang
although
emerg
test
possibl
suspect
asymptomat
case
cdc
guidelin
send
sampl
laboratori
confirm
predic
upon
combin
clinic
epidemiolog
factor
identifi
person
investig
pui
tabl
two
categori
per
cdc
confirm
case
person
laboratori
confirm
merscov
infect
confirmatori
laboratori
test
requir
posit
pcr
least
two
specif
genom
target
singl
posit
target
sequenc
second
laboratori
confirm
mer
cov
obtain
real
time
polymeras
chain
reaction
rt
pcr
probabl
case
pui
absent
inconclus
laboratori
result
merscov
infect
close
contact
laboratoryconfirm
merscov
case
exampl
laboratori
result
may
consid
inconclus
includ
posit
test
singl
pcr
target
posit
test
assay
limit
perform
data
avail
neg
test
inadequ
specimen
updat
version
interim
guidanc
document
issu
center
diseas
control
prevent
cdc
januari
base
input
public
health
partner
healthcar
provid
profession
organ
other
cdc
continu
updat
document
necessari
incorpor
new
inform
increas
understand
merscov
updat
minor
chang
made
clarifi
specimen
type
collect
procedur
emphas
recommend
collect
specimen
type
lower
respiratori
upper
respiratori
serum
possibl
one
two
three
specimen
type
test
use
cdc
mer
rrtpcr
assay
delet
recommend
collect
stool
specimen
merscov
test
provid
addit
inform
collect
process
serum
specimen
collect
handl
specimen
middl
east
respiratori
syndrom
coronaviru
merscov
test
determin
whether
person
meet
current
definit
patient
investig
pui
merscov
infect
prepar
center
diseas
control
prevent
cdc
see
case
definit
http
wwwcdcgovcoronaviru
merscasedefhtml
date
littl
known
pathogen
potenti
transmiss
dynam
merscov
increas
likelihood
detect
infect
cdc
recommend
collect
multipl
specimen
differ
site
differ
time
symptom
onset
possibl
point
consid
determin
specimen
type
collect
patient
investig
mer
includ
number
day
specimen
collect
symptom
onset
symptom
time
specimen
collect
addit
point
consid
maintain
proper
infect
control
collect
specimen
use
approv
collect
method
equip
collect
specimen
handl
store
ship
specimen
follow
appropri
protocol
collect
three
specimen
type
one
two
three
lower
respiratori
upper
respiratori
serum
specimen
test
use
cdc
mer
rrtpcr
assay
recommend
lower
respiratori
specimen
prefer
also
collect
follow
strongli
recommend
depend
upon
length
time
symptom
onset
specimen
collect
nasopharyng
oropharyng
npop
specimen
serum
strongli
recommend
depend
upon
length
time
symptom
onset
specimen
collect
note
respiratori
specimen
collect
soon
possibl
symptom
beginid
within
day
howev
week
pass
sinc
symptom
onset
patient
still
symptomat
respiratori
sampl
still
collect
especi
lower
respiratori
specimen
sinc
respiratori
virus
still
detect
rrtpcr
exampl
symptom
onset
pui
respiratori
symptom
less
day
ago
singl
serum
specimen
npop
specimen
lower
respiratori
specimen
collect
cdc
mer
rrtpcr
test
symptom
onset
pui
ongo
respiratori
tract
infect
especi
lower
day
ago
singl
serum
specimen
serolog
test
addit
lower
respiratori
specimen
npop
specimen
recommend
symptom
onset
pui
ongo
respiratori
tract
infect
especi
lower
day
ago
singl
serum
specimen
serolog
test
addit
lower
respiratori
specimen
npop
specimen
recommend
short
period
r
hour
specimen
held
rather
frozen
delay
exceed
hour
freez
specimen
soon
possibl
collect
except
note
label
specimen
contain
patient
id
number
specimen
type
date
sampl
collect
lower
respiratori
tract
broncheoalveolar
lavag
tracheal
aspir
pleural
fluid
collect
ml
steril
leakproof
screwcap
sputum
collect
cup
steril
dri
contain
refriger
specimen
hour
exceed
hour
freez
ship
dri
ice
patient
rins
mouth
water
expector
deep
cough
sputum
directli
steril
leakproof
screwcap
sputum
collect
cup
steril
dri
contain
refriger
specimen
hour
exceed
hour
freez
ship
dri
ice
upper
respiratori
tract
nasopharyng
swab
oropharyng
swab
npop
swab
use
synthet
fiber
swab
plastic
shaft
use
calcium
algin
swab
swab
wooden
shaft
may
contain
substanc
inactiv
virus
inhibit
pcr
test
place
swab
immedi
steril
tube
contain
ml
viral
transport
media
npop
specimen
combin
place
swab
vial
refriger
specimen
hour
exceed
hour
freez
ship
dri
ice
nasopharyng
swab
insert
swab
nostril
parallel
palat
leav
swab
place
second
absorb
secret
swab
nasopharyng
area
oropharyng
swab
eg
throat
swab
swab
posterior
pharynx
avoid
tongu
nasopharyng
washaspir
nasal
aspir
collect
ml
steril
leakproof
screwcap
sputum
collect
cup
steril
dri
contain
refriger
specimen
hour
exceed
hour
freez
ship
dri
ice
serum
serolog
test
serum
antibodi
test
want
delay
detect
mer
infect
sinc
preval
mer
us
low
serolog
test
singl
serum
sampl
collect
day
symptom
onset
may
benefici
contrast
serolog
test
mani
respiratori
pathogen
requir
collect
test
acut
convalesc
serum
specimen
serolog
test
current
avail
cdc
upon
request
approv
pleas
awar
merscov
serolog
test
researchsurveil
purpos
diagnost
purpos
tool
develop
respons
merscov
outbreak
contact
cdc
emerg
oper
center
eoc
consult
approv
serolog
test
consid
rrtpcr
test
ie
detect
viru
antibodi
singl
serum
specimen
collect
optim
first
day
symptom
onset
recommend
note
kinet
merscov
well
understood
addit
data
becom
avail
recommend
updat
need
minimum
amount
serum
requir
merscov
test
either
serolog
rrtpcr
ml
merscov
serolog
rrtpcr
test
plan
minimum
amount
serum
requir
ml
ml
test
serum
separ
tube
store
upright
least
minut
centrifug
rel
centrifug
forc
rcf
minut
remov
serum
place
separ
steril
tube
ship
cryovial
refriger
serum
specimen
ship
icepack
freez
shipment
serum
dri
ice
permiss
children
adult
collect
tube
ml
whole
blood
serum
separ
tube
infant
minimum
ml
whole
blood
need
test
pediatr
patient
possibl
collect
ml
serum
separ
tube
specimen
suspect
mer
case
must
packag
ship
transport
accord
current
edit
intern
air
transport
associ
iata
danger
good
regul
shipment
outsid
unit
state
may
requir
import
permit
obtain
cdc
specimen
store
ship
temperatur
indic
sampl
unabl
ship
within
hour
collect
store
ship
dri
ice
ship
frozen
specimen
long
distanc
intern
locat
best
use
combin
dri
ice
frozen
gel
icepack
gel
icepack
remain
frozen
day
two
dri
ice
dissip
specimen
must
prepack
prevent
breakag
spillag
specimen
contain
seal
parafilm
place
ziplock
bag
place
enough
absorb
materi
absorb
entir
content
secondari
contain
contain
primari
contain
separ
primari
contain
contain
specimen
prevent
breakag
send
specimen
cold
pack
refriger
block
selfcontain
actual
wet
ice
prevent
leak
appear
spill
larg
number
specimen
ship
organ
sequenti
manner
box
separ
compart
specimen
addit
use
detail
inform
pack
ship
transport
specimen
found
interim
laboratori
biosafeti
guidelin
handl
process
specimen
associ
middl
east
respiratori
syndrom
coronaviru
merscov
http
wwwcdcgovcoronavirusmersguidelineslabbiosafetyhtml
cdc
recommend
follow
place
dri
ice
primari
contain
secondari
contain
foam
envelop
ziplock
bag
cryovial
box
hermet
seal
contain
place
primari
contain
sideway
upsid
ziplock
bag
place
paperwork
secondari
contain
ziplock
bag
damag
paperwork
use
biohazardautoclav
bag
prepack
materi
due
inadequ
seal
bag
addit
inform
consult
cdc
ship
address
contact
cdc
emerg
oper
center
eoc
specimen
ship
overnight
deliveri
saturday
deliveri
plan
special
arrang
must
made
ship
compani
edit
commerci
avail
mer
cov
antivir
mainstay
therapi
mer
cov
remain
support
care
especi
respiratori
care
manag
circulatori
renal
hepat
neurolog
function
well
protect
secondari
infect
although
attempt
sar
cov
earli
mer
cov
outbreak
immun
base
interventionsinterferonresult
equivoc
outcom
nonhuman
primat
studi
use
ifn
ribavirin
mer
cov
demonstr
improv
outcom
howev
worth
note
treatment
initi
soon
viral
infect
initi
unlik
go
case
human
infect
delay
present
health
care
delay
diagnosi
like
preclud
rapid
treatment
occur
studi
role
interferon
mer
cov
remain
unclear
clinic
trial
need
better
character
success
strategi
limit
number
case
make
studi
difficult
addit
variou
interferon
treatment
protocol
ribavirina
potent
nucleosid
analogha
util
rna
virus
vari
degre
success
unfortun
ribavirin
present
risk
advers
effect
includ
hemolyt
anemia
interferon
without
side
effect
risk
either
earli
use
corticosteroid
sar
cov
infect
patient
result
increas
viral
load
critic
careintens
care
unit
admiss
death
approach
cov
includ
neutral
antibodi
convalesc
plasma
hyperimmun
globulin
may
hold
promis
reduc
cfr
convalesc
plasma
shown
decreas
mortal
sar
cov
patient
provid
patient
within
day
ill
howev
order
effect
rapid
diagnosi
patient
survivor
requir
order
obtain
util
intervent
toward
end
network
convalesc
plasma
assembl
allow
safeti
effect
logist
feasibl
test
said
date
host
deriv
intervent
shown
consist
confer
signific
benefit
sever
ill
mer
cov
patient
via
control
studi
date
antivir
current
licens
use
mer
cov
candid
drug
develop
two
categori
candid
show
earli
promis
adenin
analogu
incorpor
viral
rna
disrupt
viru
replic
shown
vitro
activ
mer
cov
well
benefit
ebola
non
human
primat
nhp
also
nucleosid
analogu
treatment
filovirus
cov
rna
virus
research
work
molecular
approach
treat
cov
anoth
promis
approach
includ
monoclon
antibodi
mab
mab
alreadi
demonstr
benefit
certain
cancer
autoimmun
disord
manag
date
pathogen
licens
mab
respiratori
syncyti
viru
rsv
recommend
standard
precaut
patient
especi
display
earli
sign
respiratori
ill
diagnosiswheth
common
cold
mer
cov
rsv
pertusi
pathogen
relat
infect
also
droplet
precaut
ad
standard
precaut
provid
care
patient
includ
acut
respiratori
ill
although
eye
protect
recommend
probabl
confirm
case
mer
cov
airborn
precaut
aerosol
gener
procedur
would
seem
prudent
even
case
clearli
mer
cov
sar
cov
infect
control
perspect
among
known
human
coronavirus
capabl
surviv
environment
surfac
hour
sar
mer
experi
well
previou
hcov
underscor
threat
transmiss
coronavirus
may
transmit
persontoperson
droplet
hand
contamin
fomit
small
particl
aerosol
underscor
risk
nosocomi
infect
outbreak
republ
korea
involv
case
health
care
set
result
singl
import
case
human
human
transmiss
famili
contact
healthcar
worker
patient
share
ward
note
environment
contamin
potenti
mer
cov
surviv
surfac
may
contribut
outbreak
recent
outbreak
jordan
nation
guard
hospit
riyadh
occur
involv
case
respect
unlik
potenti
pathogen
spread
overcrowd
health
care
residenti
facil
facilit
transmiss
mer
cov
respiratori
contagion
lesson
learn
saudi
arabia
korea
elsewher
serv
catalyz
effort
implement
enhanc
infect
control
clinic
practic
set
avoid
camel
especi
dromedari
camel
farm
well
consum
raw
milk
urin
meat
also
worth
consid
camel
infect
mer
cov
may
appear
ill
contact
anim
especi
dromedari
camel
avoid
strict
hand
wash
recommend
person
protect
includ
faceey
work
camel
anim
patient
must
travel
region
encourag
present
health
care
facil
especi
fever
respiratori
symptom
develop
accord
updat
multipl
case
unit
arab
emir
qatar
oman
kuwait
bahrain
link
dromedari
camel
patient
thought
infect
via
contact
infect
dromedari
close
primari
case
uae
good
practic
anyon
work
potenti
contaminantswheth
us
middl
east
farmremov
work
cloth
may
carri
materi
farm
anim
contact
poster
date
case
occur
europ
us
howev
emerg
medic
tourismcosmet
advanc
surgeriespati
resid
middl
east
may
bring
diseas
endem
region
includ
mer
cov
astut
clinician
awar
potenti
import
ill
cdc
provid
follow
travel
warn
person
plan
visit
region
mer
cov
remain
poster
inform
call
visit
wwwcdcgovtravel
vaccin
vaccin
critic
import
prevent
measur
public
mer
cov
vaccin
avail
merscov
continu
caus
ill
sinc
emerg
mortal
rate
estim
remain
potenti
pandem
threat
danger
diseas
caus
pathogen
sar
cov
viral
threat
public
health
concern
great
need
prophylact
measuresvaccin
target
therapi
signific
research
effort
underway
intern
develop
effect
vaccin
sar
cov
varieti
approach
one
attempt
show
earli
anim
efficaci
vaccin
candid
consist
chimer
viruslik
particl
vlp
express
receptor
bind
domain
rbd
merscov
research
fuse
canin
parvoviru
cpv
structur
protein
gene
rbd
merscov
selfassembl
chimer
spheric
vlp
svlp
svlp
retain
certain
parvoviru
characterist
abil
agglutin
pig
erythrocyt
structur
morpholog
similar
cpv
virion
immun
svlp
induc
rbdspecif
humor
cellular
immun
respons
mice
svlpspecif
antisera
anim
abl
prevent
pseudotyp
merscov
entri
suscept
cell
neutral
antibodi
titer
reach
note
interferon
ifn
secret
cell
induc
rbd
detect
splenocyt
vaccin
mice
elispot
mice
given
svlp
adjuv
svlp
vaccin
elicit
thelper
thelper
cellmedi
immun
although
earli
stage
research
svlp
display
rbd
merscov
may
becom
lead
effect
vaccin
merscov
human
research
need
tabl
person
investig
pui
sever
ill
histori
travel
countri
near
arabian
peninsula
within
day
symptom
onset
close
contact
symptomat
travel
develop
fever
acut
respiratori
ill
necessarili
pneumonia
within
day
travel
countri
near
arabian
peninsula
fever
pneumonia
acut
respiratori
distress
syndrom
base
clinic
radiolog
evid
member
cluster
patient
sever
acut
respiratori
ill
eg
fever
pneumonia
requir
hospit
unknown
etiolog
merscov
evalu
consult
state
local
health
depart
us
histori
healthcar
facil
patient
worker
visitor
within
day
symptom
onset
countri
territori
near
arabian
peninsula
recent
healthcareassoci
case
mer
identifi
fever
symptom
respiratori
ill
necessarili
pneumonia
eg
cough
short
breath
fever
symptom
respiratori
ill
necessarili
pneumonia
eg
cough
short
breath
close
contact
confirm
mer
case
case
ill
footnot
fever
may
present
patient
young
elderli
immunosuppress
take
certain
medic
clinic
judgment
use
guid
test
patient
situat
countri
consid
arabian
peninsula
neighbor
includ
bahrain
iraq
iran
israel
west
bank
gaza
jordan
kuwait
lebanon
oman
qatar
saudi
arabia
syria
unit
arab
emir
uae
yemen
close
contact
defin
within
approxim
feet
meter
within
room
care
area
confirm
mer
case
prolong
period
time
care
live
visit
share
healthcar
wait
area
room
confirm
mer
case
wear
recommend
person
protect
equip
ppe
eg
gown
glove
nioshcertifi
dispos
respir
eye
protect
b
direct
contact
infecti
secret
confirm
mer
case
eg
cough
wear
recommend
person
protect
equip
see
cdc
interim
infect
prevent
control
recommend
hospit
patient
mer
http
wwwcdcgovcoronavirusmersinfectionpreventioncontrolhtml
data
inform
definit
close
contact
limit
consider
assess
close
contact
includ
durat
exposur
eg
longer
exposur
time
like
increas
exposur
risk
clinic
symptom
person
mer
eg
cough
like
increas
exposur
risk
special
consider
given
expos
healthcar
set
